Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 148 of 148 entries
Sorted by: Best Match Show Resources per page
Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement.

Journal of controlled release : official journal of the Controlled Release Society

Estapé Senti M, de Jongh CA, Dijkxhoorn K, Verhoef JJF, Szebeni J, Storm G, Hack CE, Schiffelers RM, Fens MH, Boross P.
PMID: 34890719
J Control Release. 2021 Dec 07;341:475-486. doi: 10.1016/j.jconrel.2021.11.042. Epub 2021 Dec 07.

PEGylation of lipid-based nanoparticles and other nanocarriers is widely used to increase their stability and plasma half-life. However, either pre-existing or de novo formed anti-PEG antibodies can induce hypersensitivity reactions and accelerated blood clearance through binding to the nanoparticle...

Cite
Estapé Senti M, de Jongh CA, Dijkxhoorn K, et al. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. J Control Release. 2021;341:475-486doi: 10.1016/j.jconrel.2021.11.042.
Estapé Senti, M., de Jongh, C. A., Dijkxhoorn, K., Verhoef, J. J. F., Szebeni, J., Storm, G., Hack, C. E., Schiffelers, R. M., Fens, M. H., & Boross, P. (2021). Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. Journal of controlled release : official journal of the Controlled Release Society, 341475-486. https://doi.org/10.1016/j.jconrel.2021.11.042
Estapé Senti, Mariona, et al. "Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement." Journal of controlled release : official journal of the Controlled Release Society vol. 341 (2021): 475-486. doi: https://doi.org/10.1016/j.jconrel.2021.11.042
Estapé Senti M, de Jongh CA, Dijkxhoorn K, Verhoef JJF, Szebeni J, Storm G, Hack CE, Schiffelers RM, Fens MH, Boross P. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. J Control Release. 2021 Dec 07;341:475-486. doi: 10.1016/j.jconrel.2021.11.042. Epub 2021 Dec 07. PMID: 34890719.
Copy Download .nbib Format: NLM
Efficacy of Sesame (Sesamum indicum L.) in the Management of Incomplete Abortion: An Open-Label Randomized Controlled Clinical Trial.

Complementary medicine research

Aghababaei Z, Nejatbakhsh F, Mazaheri M, Shirazi M, Feizi A, Bozorgi M, Bioos S.
PMID: 34192691
Complement Med Res. 2021;28(6):501-507. doi: 10.1159/000510901. Epub 2021 Jun 30.

BACKGROUND: Incomplete abortion is a common complication of pregnancy. Sesamum indicum L. is a widely used emmenagogue herb.OBJECTIVES: We designed a clinical trial to evaluate the efficacy of sesame for the removal of retained products of conception (RPOC).METHODS: In...

Cite
Aghababaei Z, Nejatbakhsh F, Mazaheri M, et al. Wirksamkeit von Sesam (Sesamum indicum L.) im Management des unvollständigen Aborts: Eine unverblindete, randomisierte, kontrollierte klinische Studie. Efficacy of Sesame (Sesamum indicum L.) in the Management of Incomplete Abortion: An Open-Label Randomized Controlled Clinical Trial. Complement Med Res. 2021;28(6):501-507doi: 10.1159/000510901.
Aghababaei, Z., Nejatbakhsh, F., Mazaheri, M., Shirazi, M., Feizi, A., Bozorgi, M., & Bioos, S. (2021). Wirksamkeit von Sesam (Sesamum indicum L.) im Management des unvollständigen Aborts: Eine unverblindete, randomisierte, kontrollierte klinische Studie. Efficacy of Sesame (Sesamum indicum L.) in the Management of Incomplete Abortion: An Open-Label Randomized Controlled Clinical Trial. Complementary medicine research, 28(6), 501-507. https://doi.org/10.1159/000510901
Aghababaei, Zahra, et al. "Wirksamkeit von Sesam (Sesamum indicum L.) im Management des unvollständigen Aborts: Eine unverblindete, randomisierte, kontrollierte klinische Studie." Efficacy of Sesame (Sesamum indicum L.) in the Management of Incomplete Abortion: An Open-Label Randomized Controlled Clinical Trial. Complementary medicine research vol. 28,6 (2021): 501-507. doi: https://doi.org/10.1159/000510901
Aghababaei Z, Nejatbakhsh F, Mazaheri M, Shirazi M, Feizi A, Bozorgi M, Bioos S. Wirksamkeit von Sesam (Sesamum indicum L.) im Management des unvollständigen Aborts: Eine unverblindete, randomisierte, kontrollierte klinische Studie. Efficacy of Sesame (Sesamum indicum L.) in the Management of Incomplete Abortion: An Open-Label Randomized Controlled Clinical Trial. Complement Med Res. 2021;28(6):501-507. doi: 10.1159/000510901. Epub 2021 Jun 30. PMID: 34192691.
Copy Download .nbib Format: NLM
Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance.

Frontiers in neurology

Kocsis K, Szabó N, Tóth E, Király A, Faragó P, Kincses B, Veréb D, Bozsik B, Boross K, Katona M, Bodnár P, László NG, Vécsei L, Klivényi P, Bencsik K, Kincses ZT.
PMID: 33746876
Front Neurol. 2021 Mar 03;12:619135. doi: 10.3389/fneur.2021.619135. eCollection 2021.

No abstract available.

Cite
Kocsis K, Szabó N, Tóth E, et al. Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance. Front Neurol. 2021;12:619135doi: 10.3389/fneur.2021.619135.
Kocsis, K., Szabó, N., Tóth, E., Király, A., Faragó, P., Kincses, B., Veréb, D., Bozsik, B., Boross, K., Katona, M., Bodnár, P., László, N. G., Vécsei, L., Klivényi, P., Bencsik, K., & Kincses, Z. T. (2021). Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance. Frontiers in neurology, 12619135. https://doi.org/10.3389/fneur.2021.619135
Kocsis, Krisztián, et al. "Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance." Frontiers in neurology vol. 12 (2021): 619135. doi: https://doi.org/10.3389/fneur.2021.619135
Kocsis K, Szabó N, Tóth E, Király A, Faragó P, Kincses B, Veréb D, Bozsik B, Boross K, Katona M, Bodnár P, László NG, Vécsei L, Klivényi P, Bencsik K, Kincses ZT. Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance. Front Neurol. 2021 Mar 03;12:619135. doi: 10.3389/fneur.2021.619135. eCollection 2021. PMID: 33746876; PMCID: PMC7966518.
Copy Download .nbib Format: NLM
Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model.

International journal of molecular sciences

Fang CH, Sun CK, Lin YW, Hung MC, Lin HY, Li CH, Lin IP, Chang HC, Sun JS, Chang JZ.
PMID: 35008984
Int J Mol Sci. 2022 Jan 05;23(1). doi: 10.3390/ijms23010558.

In this study, we fabricated gelatin/nano-hydroxyapatite/metformin scaffold (GHMS) and compared its effectiveness in bone regeneration with extraction-only, Sinbone, and Bio-Oss Collagen

Cite
Fang CH, Sun CK, Lin YW, et al. Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model. Int J Mol Sci. 2022;23(1)doi: 10.3390/ijms23010558.
Fang, C. H., Sun, C. K., Lin, Y. W., Hung, M. C., Lin, H. Y., Li, C. H., Lin, I. P., Chang, H. C., Sun, J. S., & Chang, J. Z. (2022). Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010558
Fang, Chih-Hsiang, et al. "Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model." International journal of molecular sciences vol. 23,1 (2022). doi: https://doi.org/10.3390/ijms23010558
Fang CH, Sun CK, Lin YW, Hung MC, Lin HY, Li CH, Lin IP, Chang HC, Sun JS, Chang JZ. Metformin-Incorporated Gelatin/Nano-Hydroxyapatite Scaffolds Promotes Bone Regeneration in Critical Size Rat Alveolar Bone Defect Model. Int J Mol Sci. 2022 Jan 05;23(1). doi: 10.3390/ijms23010558. PMID: 35008984.
Copy Download .nbib Format: NLM
Showing 145 to 148 of 148 entries